BELLICUM PHARMACEUTICALS (BLCM) Covered Calls

Bellicum Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It discovers and develops novel cellular immunotherapies of cancer including both hematological cancers and solid tumors, as well as orphan inherited blood disorders.

You can sell covered calls on BELLICUM PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BLCM (prices last updated Tue 11:30 AM ET):

BELLICUM PHARMACEUTICALS (BLCM) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.80 -0.15 4.80 4.81 87K - 0.2B
Covered Calls For BELLICUM PHARMACEUTICALS (BLCM)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Nov 16 5 0.25 4.56 5.5% 80.3%
Dec 21 5 0.50 4.31 11.6% 70.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Bellicum Pharmaceutivals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors, as well as orphan inherited blood disorders. It develops chemical induction of dimerization technology platform to engineer and control components of the immune system. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.